Status:
UNKNOWN
The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
50-70 years
Brief Summary
Alzheimer's disease (AD) is a prevalent, long-term progressive degenerative disorder with great social impact. It is currently thought that, in addition to neurodegeneration, vascular changes also pla...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Alzheimer's Disease
Exclusion
- neurologic disorders
- psychiatric disorders
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04277767
Start Date
September 1 2022
End Date
July 1 2023
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China, 510000